NIH
ACTIV Initiative Launches Adaptive Clinical Trials of Blood-clotting Treatments for COVID-19
Agency Funds Community Engagement Research Efforts in Areas Hardest Hit by COVID-19
Agency Continues to Boost National COVID-19 Testing Capacity

Agency-supported Study Tracks Prevalence/Impact of SARS-CoV-2 Among Pregnant Women in . . .

Phase 3 Clinical Testing in US of AstraZeneca COVID-19 Vaccine Candidate Begins

Mapping Tool Highlights
NIH-funded Small Business Successes

Clinical Trials of Monoclonal Antibodies to Prevent COVID-19 Now Enrolling
Clinical Trial Testing Remdesivir Plus Interferon Beta-1a For COVID-19 Treatment Begins

Agency-funded Project Seeks to Identify Children at Risk for MIS-C
Clinical Trials of Monoclonal Antibodies to Prevent COVID-19 Now Enrolling

Clinical Trial to Test Antibody Treatment in Hospitalized COVID-19 Patients Launched
NIH-Moderna Investigational COVID-19 Vaccine Shows Promise in Mouse Studies
Agency Harnesses AI for COVID-19 Diagnosis, Treatment, and Monitoring

Clinical Trial to Test Antibodies and Other Experimental Therapeutics for Mild/Moderate COVID-19

Agency Delivering New COVID-19 Testing Technologies to Meet U.S. Demand
Experimental COVID-19 Vaccine Protects Upper and Lower Airways in Nonhuman Primates
Phase 3 Clinical Trial of Investigational Vaccine for COVID-19 Begins
Agency Leadership Details Unprecedented Initiative to Ramp Up Testing Technologies for COVID-19
Agency-Wide Strategic Plan for COVID-19 Research
Experimental COVID-19 Vaccine Safe, Generates Immune Response
Placenta Lacks Major Molecules Used by SARS-CoV-2 Virus to Cause Infection

Agency-wide Strategic Plan for COVID-19 Research
Clinical Trials Network to Test COVID-19 Vaccines and Other Prevention Tools Launched
ACTIV vaccine working group weighs role of human challenge studies for SARS-CoV-2 vaccine development

COVID-19 Treatment Guidelines Panel Provides Recommendations for Dexamethasone in Patients with COVID-19
Updated: Special Considerations in Children
Investigators Hope CD47 Study Leads to Broad-spectrum Infectious Diseases Immunotherapy
Experts ID Steps to Expand/Improve Antibody Tests in COVID-19 Response
Clinical Trials of Hydroxychloroquine Halted
All of Us Research Pgm Launches COVID-19 research initiatives
Analytics Platform to Harness Nationwide COVID-19 Patient Data to Speed Treatments Launched
Researchers ID Key Genomic Features: Could Differentiate SARS-CoV-2 From Other Coronaviruses That Cause Less Severe Disease
Study identifies potential approach to treat severe respiratory distress in COVID-19 patients
NIH-funded study evaluates drugs prescribed to children w/COVID-19
What’s New in Treatment Guidelines

COVID-19: Treatment Guidelines
Initiative mobilizes national innovation for COVID-19 diagnostics
ACTIV Research Initiative: ACCELERATING COVID-19 THERAPEUTIC INTERVENTIONS AND VACCINES
COVID-19 Treatment Guidelines